American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2020, 8(12), 453-455
DOI: 10.12691/ajmcr-8-12-5
Open AccessArticle

Schizophrenia: An Observational Study and Demonstration that Alpha-emitting Nanoparticulates Effect Is not Hereditary but Direct in the Brain (Explaining Core Relation with TBI)

Florent Pirot1,

1Independent researcher, Valbonne, France

Pub. Date: August 31, 2020

Cite this paper:
Florent Pirot. Schizophrenia: An Observational Study and Demonstration that Alpha-emitting Nanoparticulates Effect Is not Hereditary but Direct in the Brain (Explaining Core Relation with TBI). American Journal of Medical Case Reports. 2020; 8(12):453-455. doi: 10.12691/ajmcr-8-12-5

Abstract

A case study (with involvement of the author in various observational settings and many subjects) leads to confirmation of the general link between schizophrenia and traumatic brain injury that was already underlined in the existing literature. The effects of the welfare State conceal the core idea that schizophrenia can hence be healed radically because the existence of monetary incomes for people suffering of mental disease triggers an incentive to self-contaminate and maintain the state of dereliction of the brain instead of actually contributing to society. This case study allows to prove that second statement and to confirm as well general demands of French economist Jacques Rueff. The issue of marijuana risks is also discussed, confirming the dangers of marijuana (THC, THCa only) in a situation in which the brain is contaminated.

Keywords:
TBI schizophrenia public health concepts of health management socialism marijuana

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Pirot, F, “Alpha-emitting nanoparticulates, the forgotten pollutant”, in From an Einstein Syndrome to the People, 2019, Editions universitaires européennes.
 
[2]  Pirot, F. “The link between salt and neurological disorders -the mediation of alpha-emitting nanoparticulates as simple explanation”, Porto Biomedical Journal, 4 (6). pe 55. 2019.
 
[3]  Pirot, F. 'Traumatic Brain Injury: a Case Report and Its Contribution to Understanding the Underlying Mechanisms - Alpha-Emitting Nanoparticulates Proven as Key.' American Journal of Medical Case Reports 8, no. 4 (2020): 100-102.
 
[4]  Miller AC, Rivas R, Tesoro L, Kovalenko G, Kovaric N, Pavlovic P, Brenner D, “Radiation exposure from depleted uranium: The radiation bystander effect”, Toxicology and Applied Pharmacology, 331 (15). 135-141. Sept 2017.
 
[5]  Molloy, C., Conroy, R. M., Cotter, D. R., & Cannon, M. (2011). Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies. Schizophrenia bulletin, 37(6), 1104-1110.
 
[6]  Hart S, Fischer OM, Ullrich A. Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 2004; 64(6): 1943-1950.
 
[7]  Khan, M. I., Sobocińska, A. A., Brodaczewska, K. K., Zielniok, K., Gajewska, M., Kieda, C., Czarnecka, A. M., & Szczylik, C, Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212-2 in renal cell carcinoma. BMC Cancer 18, 583 (2018).
 
[8]  Galve-Roperh I, Chiurchiù V, Díaz-Alonso J, Bari M, Guzmán M, Maccarrone M. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Prog Lipid Res. 2013; 52(4): 633-650.
 
[9]  De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci U S A. 1998 Jul 7; 95(14): 8375-80.
 
[10]  Hagihara, H., Catts, V. S., Katayama, Y., Shoji, H., Takagi, T., Huang, F. L., Nakao, A., Mori, Y., Huang, K. P., Ishii, S., Graef, I. A., Nakayama, K. I., Shannon Weickert, C., & Miyakawa, T. (2018). Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 43(3), 459-468.